Tetrahydroxy Cyclic Urea-Potent Inhibitor for HIV-1 Protease Wild Type and Mutant Type—A Computational Design
A series of novel tetrahydroxy cyclic urea molecules as HIV-1 protease inhibitors were designed using computational techniques. The designed molecules were compared with the known cyclic urea molecules by performing docking studies on six of wild type protein and three mutant protein varieties and c...
Saved in:
Main Authors: | S. Sree Kanth, M. Vijjulatha |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2008-01-01
|
Series: | E-Journal of Chemistry |
Online Access: | http://dx.doi.org/10.1155/2008/154030 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comparative Molecular Field Analysis (CoMFA) for Thiotetrazole Alkynylacetanilides, a Non-Nucleoside Inhibitor of HIV-1 Double Mutant K103N/Y181C Reverse Transcriptase
by: Sivan Sree Kanth, et al.
Published: (2009-01-01) -
CoMFA and CoMSIA Studies on Inhibitors of HIV-1 Integrase - Bicyclic Pyrimidinones
by: V. Radhika, et al.
Published: (2010-01-01) -
Evaluation of COVID-19 protease and HIV inhibitors interactions
by: Tran Linh, et al.
Published: (2022-03-01) -
Comparative Evaluation of Agroindustrial Byproducts for the Production of Alkaline Protease by Wild and Mutant Strains of Bacillus subtilis in Submerged and Solid State Fermentation
by: Hamid Mukhtar, et al.
Published: (2013-01-01) -
Inhibitors of Human Dihydrofolate Reductase: A Computational Design and Docking Studies Using Glide
by: Lingala Yamini, et al.
Published: (2008-01-01)